Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors-Reference-Cited by-同舟云学术

Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors

Published:2021-06-23 Issue:4 Volume:88 Page:643-654
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Maguire William F.^ORCID,Schmitz John C.^ORCID,Scemama Jonas,Czambel Ken,Lin Yan^ORCID,Green Anthony G.,Wu Shaoyu,Lin Huang,Puhalla Shannon,Rhee John,Stoller Ronald,Tawbi Hussein,Lee James J.,Wright John J.,Beumer Jan H.^ORCID,Chu Edward,Appleman Leonard J.^ORCID,

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-021-04317-y.pdf

Reference40 articles.

1. Corso S, Giordano S (2013) Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective. Cancer Discov 3:978–992. https://doi.org/10.1158/2159-8290.CD-13-0040

2. Bylicki O, Paleiron N, Assié J-B, Chouaïd C (2020) Targeting the MET-signaling pathway in non-small-cell lung cancer: evidence to date. Onco Targets Ther 13:5691–5706. https://doi.org/10.2147/OTT.S219959

3. Moosavi F, Giovannetti E, Saso L, Firuzi O (2019) HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers. Crit Rev Clin Lab Sci 56:533–566. https://doi.org/10.1080/10408363.2019.1653821

4. Parikh PK, Ghate MD (2018) Recent advances in the discovery of small molecule c-Met kinase inhibitors. Eur J Med Chem 143:1103–1138. https://doi.org/10.1016/j.ejmech.2017.08.044

5. Wu P, Clausen MH, Nielsen TE (2015) Allosteric small-molecule kinase inhibitors. Pharmacol Ther 156:59–68. https://doi.org/10.1016/j.pharmthera.2015.10.002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tepotinib and tivantinib as potential inhibitors for the serine/threonine kinase of the mpox virus: insights from structural bioinformatics analysis;Journal of Biomolecular Structure and Dynamics;2024-03-26

2. Absorption, Distribution, Metabolism and Excretion of Novel Drug Delivery Systems;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

3. MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells;Frontiers in Oncology;2022-08-29